Filing Details
- Accession Number:
- 0001127602-21-012256
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-29 18:53:05
- Reporting Period:
- 2021-03-26
- Accepted Time:
- 2021-03-29 18:53:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 64803 | Cvs Health Corp | CVS | Retail-Drug Stores And Proprietary Stores (5912) | 050494040 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1194413 | J Larry Merlo | One Cvs Drive Woonsocket RI 02895- | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-26 | 271,347 | $74.29 | 794,676 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-26 | 270,650 | $74.73 | 524,026 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2021-03-26 | 271,347 | $0.00 | 271,347 | $74.29 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-04-01 | 2021-04-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 406,633 | Indirect | By Trust As Beneficiary |
| Common Stock (Restricted) | 40,701 | Direct | |
| Esop Common Stock | 7,548 | Indirect | By ESOP |
| Stock Unit | 688,686 | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Phantom Stock Credits | $1.00 | 5,153 | 5,153 | Direct | ||
| Common Stock | Stock Option | $102.26 | 2016-04-01 | 2022-04-01 | 273,929 | 273,929 | Direct |
| Common Stock | Stock Option | $104.82 | 2017-04-01 | 2023-04-01 | 286,787 | 286,787 | Direct |
| Common Stock | Stock Option | $78.05 | 2018-04-03 | 2024-04-03 | 338,105 | 338,105 | Direct |
| Common Stock | Stock Option | $62.21 | 2019-04-01 | 2025-04-01 | 394,091 | 394,091 | Direct |
| Common Stock | Stock Option | $54.19 | 2020-04-01 | 2029-04-01 | 545,419 | 545,419 | Direct |
| Common Stock | Stock Option | $58.34 | 2021-04-01 | 2030-04-01 | 478,711 | 478,711 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 5,153 | 5,153 | Direct | |
| 2022-04-01 | 273,929 | 273,929 | Direct |
| 2023-04-01 | 286,787 | 286,787 | Direct |
| 2024-04-03 | 338,105 | 338,105 | Direct |
| 2025-04-01 | 394,091 | 394,091 | Direct |
| 2029-04-01 | 545,419 | 545,419 | Direct |
| 2030-04-01 | 478,711 | 478,711 | Direct |
Footnotes
- All sales were effected pursuant to a Rule 10b5-1 Plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the Reporting Person retaining all remaining shares.
- Represents weighted average sale prices for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $74.49 and $75.73 per share.
- Option became exercisable in four equal annual installments, commencing 4/1/2015.
- Each share credit is equivalent to one share; 1-for-1 conversion.
- Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
- Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
- Option became exercisable in four equal annual installments, commencing 4/1/2016.
- Option became exercisable in four equal annual installments, commencing 4/1/2017.
- Option became exercisable in four equal annual installments, commencing 4/3/2018.
- Option became exercisable in four equal annual installments, commencing 4/1/2019.
- Option became exercisable in four equal annual installments, commencing 4/1/2020.
- The number of shares subject to the option were calculated using a 30-day average price.
- Option becomes exercisable in four equal annual installments, commencing 4/1/2021.
Billionaire Hedge Funds
